Gladius Capital Management’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.47M | Buy |
31,300
+5,400
| +21% | +$1.61M | 0.38% | 68 |
|
|
2025
Q4 | $8.55M | Buy |
25,900
+12,100
| +88% | +$4.1M | 0.47% | 47 |
|
|
2025
Q3 | $4.77M | Buy |
13,800
+9,400
| +214% | +$2.84M | 0.5% | 47 |
|
|
2025
Q2 | $1.37M | Sell |
4,400
-4,900
| -53% | -$1.87M | 0.5% | 32 |
|
|
2025
Q1 | $4.87M | Sell |
9,300
-115,400
| -93% | -$59M | 1.3% | 22 |
|
|
2024
Q4 | $63.1M | Buy |
124,700
+108,600
| +675% | +$61.7M | 6.77% | 2 |
|
|
2024
Q3 | $9.41M | Buy |
16,100
+4,300
| +36% | +$2.43M | 1.13% | 17 |
|
|
2024
Q2 | $6.01M | Buy |
11,800
+5,600
| +90% | +$2.74M | 0.74% | 14 |
|
|
2024
Q1 | $3.07M | Hold |
6,200
| – | – | 1.01% | 16 |
|
|
2023
Q4 | $3.26M | Sell |
6,200
-29,000
| -82% | -$15.5M | 0.51% | 42 |
|
|
2023
Q3 | $17.7M | Buy |
35,200
+23,400
| +198% | +$11.5M | 0.74% | 30 |
|
|
2023
Q2 | $5.67M | Sell |
11,800
-19,000
| -62% | -$9.29M | 0.28% | 42 |
|
|
2023
Q1 | $14.6M | Sell |
30,800
-424,700
| -93% | -$205M | 0.85% | 27 |
|
|
2022
Q4 | $241M | Buy |
455,500
+288,500
| +173% | +$153M | 17.34% | 1 |
|
|
2022
Q3 | $84.3M | Buy |
+167,000
| New | +$87.8M | 3.71% | 6 |
|
|
2022
Q2 | – | Sell |
-8,600
| Closed | -$4.39M | – | 432 |
|
|
2022
Q1 | $4.39M | Sell |
8,600
-2,900
| -25% | -$1.4M | 0.32% | 38 |
|
|
2021
Q4 | $5.78M | Buy |
11,500
+2,000
| +21% | +$905K | 0.46% | 39 |
|
|
2021
Q3 | $3.71M | Hold |
9,500
| – | – | 0.26% | 23 |
|
|
2021
Q2 | $3.81M | Sell |
9,500
-72,100
| -88% | -$28.7M | 0.35% | 25 |
|
|
2021
Q1 | $30.4M | Buy |
81,600
+10,900
| +15% | +$3.78M | 1.14% | 20 |
|
|
2020
Q4 | $24.8M | Buy |
70,700
+55,600
| +368% | +$18.6M | 1.22% | 20 |
|
|
2020
Q3 | $4.71M | Buy |
+15,100
| New | +$4.64M | 0.47% | 28 |
|
|
2020
Q2 | – | Sell |
-15,300
| Closed | -$3.82M | – | 112 |
|
|
2020
Q1 | $3.82M | Sell |
15,300
-19,500
| -56% | -$5.37M | 0.4% | 21 |
|
|
2019
Q4 | $10.2M | Buy |
34,800
+6,200
| +22% | +$1.62M | 0.65% | 33 |
|
|
2019
Q3 | $6.22M | Sell |
28,600
-19,000
| -40% | -$4.58M | 0.28% | 65 |
|
|
2019
Q2 | $11.6M | Sell |
47,600
-13,000
| -21% | -$3.13M | 0.69% | 24 |
|
|
2019
Q1 | $15M | Sell |
60,600
-48,800
| -45% | -$12.4M | 0.83% | 28 |
|
|
2018
Q4 | $27.3M | Buy |
109,400
+100,500
| +1,129% | +$26.5M | 1.33% | 12 |
|
|
2018
Q3 | $2.37M | Sell |
8,900
-200
| -2% | -$52K | 0.23% | 17 |
|
|
2018
Q2 | $2.23K | Buy |
+9,100
| New | +$2.19M | 0.23% | 25 |
|
Other funds holding UNH
VCM
VPM
Gladius Capital Management's UNH Position: Q1 2026 in Review
Gladius Capital Management reduced its UnitedHealth (UNH) stake by 27% in Q1 2026, selling an estimated $185K and leaving 1,663 shares worth $450K. The position accounts for 0.02% of the portfolio, ranked #99.
Gladius Capital Management first reported a position in UNH in Q2 2018 and has held it in 22 quarters since. The position peaked at $22.5M in Q4 2022. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- Gladius Capital Management held 1,663 shares of UnitedHealth worth $450K as of Q1 2026.
- Gladius Capital Management sold 620 UnitedHealth shares in Q1 2026, an estimated $185K.
- UnitedHealth made up 0.02% of Gladius Capital Management's portfolio in Q1 2026, its #99 holding.
- Gladius Capital Management first reported a position in UnitedHealth in Q2 2018 and has held it in 22 quarters since.
- Gladius Capital Management's UnitedHealth position peaked at $22.5M in Q4 2022.
- 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.